the extreme regimen for head and neck cancer
Published 1 year ago • 416 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
2:54
extreme regimen vs. cetuximab cisplatin paclitaxel for recurrent/metastatic head and neck cancer
-
3:05
asco 2020: head and neck cancer highlights
-
1:59
potential of immunotherapy in head and neck cancer
-
7:56
keynote-048: progression post next line for r/m hnscc
-
2:28
palbociclib for platinum-resistant metastatic head and neck cancer
-
2:36
ca209-9ky: imrt nivolumab for recurrent head and neck squamous cell cancer
-
1:09
the future role of immunotherapy in head and neck cancers
-
3:28
head and neck cancer challenges & cetuximab trial updates
-
3:12
novel immunotherapy approaches in metastatic head and neck cancer
-
1:52
esmo 2022 highlights in head and neck cancer
-
2:12
unanswered questions in head and neck cancer
-
1:37
the future role of immunotherapy in head and neck cancer
-
3:34
irec: international center for recurrent head and neck cancer
-
2:55
tacti-002 and tacti-003: eftilagimod alpha for metastatic head and neck squamous cell carcinoma
-
1:36
addition of an egfr/tgfβ inhibitor with pembrolizumab in head and neck cancer
-
1:39
metronomic chemotherapy for head and neck cancer
-
2:41
advances in head and neck cancer
-
4:03
keynote-040: groundbreaking results for pembrolizumab in head and neck cancer
-
2:53
positive results for palbociclib/cetuximab therapy in head and neck cancer